Table 1.
IHC/FISH | SNP array | ||||
---|---|---|---|---|---|
Tumor sample number | HER2 IHC | HER2 FISH | HER2 segment copy number | HER2/CEP17 ratio | HER2 copy number status |
1 | 0 | n/a | 1,98 | balance | normal |
2 | 0 | n/a | 2,35 | HER2+ | amp* |
3 | 0 | 1,92 | 1,81 | balance | normal |
4 | 0 | n/a | 2,06 | balance | normal |
5 | 0 | n/a | 2,04 | balance | normal |
6 | 0 | n/a | 1,72 | cent+ | del |
7 | 0 | n/a | 1,67 | balance | del |
8 | 0 | n/a | 1,83 | balance | normal |
9 | 0 | n/a | 1,51 | cent+ | del |
10 | 0 | n/a | 2,51 | balance | amp* |
11 | 0 | n/a | 1,78 | balance | del |
12 | 0 | n/a | 1,85 | balance | normal |
13 | 1 | n/a | 1,97 | balance | normal |
14 | 1 | n/a | 2,08 | balance | normal |
15 | 1 | 0,83 | 2,33 | balance | amp* |
16 | 1 | 0,80 | 1,70 | balance | del |
17 | 1 | 0,80 | 1,80 | cent+ | normal |
18 | 1 | 0,86 | 2,49 | balance | amp* |
19 | 1 | n/a | 2,06 | balance | normal |
20 | 1 | n/a | 2,09 | balance | normal |
21 | 1 | n/a | 1,96 | balance | normal |
22 | 1 | n/a | 1,97 | balance | normal |
23 | 1 | n/a | 2,13 | balance | normal |
24 | 1 | n/a | 1,90 | balance | normal |
25 | 1 | n/a | 1,87 | balance | normal |
26 | 1 | n/a | 4,46 | balance | amp* |
27 | 1 | n/a | 2,34 | balance | amp* |
28 | 2 | 1,41 | 2,45 | balance | amp* |
29 | 2 | 1,54 | 2,16 | balance | normal |
30 | 2 | 3,05* | 2,04 | balance | normal |
31 | 2 | 2,69* | 2,48 | balance | amp* |
32 | 2 | 2,42* | 1,75 | cent+ | del |
33 | 2 | 1,73 | 1,99 | balance | normal |
34 | 2 | 2,65* | 1,92 | balance | normal |
35 | 2 | 1,50 | 1,91 | balance | normal |
36 | 2 | 1,57 | 2,00 | balance | normal |
37 | 2 | 1,68 | 1,79 | balance | del |
38 | 2 | 1,90 | 1,84 | balance | normal |
39 | 2 | 1,60 | 2,05 | balance | normal |
40 | 2 | 1,58 | 1,89 | balance | normal |
41 | 2 | 2,13* | 2,73 | balance | amp* |
42 | 2 | 1,54 | 2,04 | balance | normal |
43 | 2 | 1,82 | 1,54 | balance | del |
44 | 2 | 1,90 | 1,77 | balance | del |
45 | 2 | 1,66 | 2,33 | balance | amp* |
46 | 2 | 1,48 | 2,04 | balance | normal |
47 | 2 | 1,73 | 1,98 | balance | normal |
48 | 2 | 1,67 | 2,36 | balance | amp* |
49 | 2/3 | 0,93/8,8 | 11,10 | HER2+ | amp* |
50 | 2 | 1,81 | 2,04 | balance | normal |
51 | 2 | 1,58 | 2,65 | HER2+ | amp* |
52 | 2 | 1,60 | 2,23 | balance | amp* |
53 | 2 | 2,27* | 8,03 | HER2+ | amp* |
54 | 2 | 1,87 | 2,91 | balance | amp* |
55 | 2 | 1,24 | 2,66 | balance | amp* |
56 | 2 | 7,38* | 7,01 | HER2+ | amp* |
57 | 2 | 1,00 | 1,88 | balance | normal |
58 | 2 | 8,60* | 7,98 | HER2+ | amp* |
59 | 2 | 3,24* | 3,18 | HER2+ | amp* |
60 | 3*/1 | 1,65 | 2,00 | balance | normal |
61 | 3 | 4,11* | 5,28 | HER2+ | amp* |
62 | 3 | 7,00* | 4,58 | HER2+ | amp* |
63 | 3*/2 | 1,50 | 2,05 | balance | normal |
64 | 3* | n/a | 3,15 | HER2+ | amp* |
65 | 3* | 1,35 | 3,75 | HER2+ | amp* |
Asterisk indicates HER2 positive results, while bold indicates samples that have been reanalyzed. Abbreviations: amp amplified CEP17 centromere on chromosome 17, del deletion, FISH fluorescent in situ hybridization, HER2 human epidermal growth factor receptor-2, IHC immunohistochemistry, n/a not analysed.